Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00174499Phase 4Completed
Phase 4, open-label trial of nicotine in nicotine dependence (2 arms), sponsored by McNeil Laboratories. Primary endpoint: Amount of extrinsic tooth-stain reduction from Baseline at 6 weeks. Started Jul 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00174499.